or
forgot password

    • cancer clinical trials in great falls, MT

    • S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer
    Big Sky Oncology

    Trial Locations
    Big Sky Oncology
    Great Falls Clinic - Main Facility
    Sletten Cancer Institute at Benefis Healthcare
    Breast Cancer
    Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
    Sletten Cancer Institute at Benefis Healthcare

    Trial Locations
    Sletten Cancer Institute at Benefis Healthcare
    Lymphoma
    Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
    Sletten Cancer Institute at Benefis Healthcare
    Great Falls, Montana 59405
    Metastatic Cancer, Prostate Cancer
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Great Falls Clinic

    Trial Locations
    Great Falls Clinic
    Big Sky Oncology
    Benefis Healthcare- Sletten Cancer Institute
    Berdeaux, Donald MD (UIA Investigator)
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Creatine in Treating Patients With Cancer-Associated Weight Loss

    Great Falls, Montana 59405
    Anorexia, Cachexia, Unspecified Adult Solid Tumor, Protocol Specific, Weight Changes
    S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML
    Big Sky Oncology

    Trial Locations
    Big Sky Oncology
    Great Falls Clinic - Main Facility
    Sletten Cancer Institute at Benefis Healthcare
    Leukemia
    Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission
    Berdeaux, Donald MD (UIA Investigator)
    Great Falls, Montana 59405
    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Recurrent Adult Acute Myeloid Leukemia, Refractory Anemia With Excess Blasts in Transformation
    Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer
    Great Falls Clinic

    Trial Locations
    Great Falls Clinic
    Big Sky Oncology
    Sletten Regional Cancer Institute at Benefis Healthcare
    Colorectal Cancer
    Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Treating Older Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma
    Big Sky Oncology

    Trial Locations
    Big Sky Oncology
    Great Falls Clinic - Main Facility
    Sletten Cancer Institute at Benefis Healthcare
    Lymphoma
    S0333 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Sletten Cancer Institute at Benefis Healthcare

    Trial Locations
    Sletten Cancer Institute at Benefis Healthcare
    Frontier Cancer Center
    Leukemia
    CCI-779 and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
    Great Falls Clinic

    Trial Locations
    Great Falls Clinic
    Berdeaux, Donald MD (UIA Investigator)
    Recurrent Mantle Cell Lymphoma
    Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer
    Sletten Cancer Institute at Benefis Healthcare

    Trial Locations
    Sletten Cancer Institute at Benefis Healthcare
    Breast Cancer
    Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
    Great Falls Clinic - Main Facility

    Trial Locations
    Great Falls Clinic - Main Facility
    Sletten Cancer Institute at Benefis Healthcare
    Metastatic Cancer, Prostate Cancer
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Great Falls Clinic

    Trial Locations
    Great Falls Clinic
    Big Sky Oncology
    Benefis Healthcare- Sletten Cancer Institute
    Berdeaux, Donald MD (UIA Investigator)
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    S0353, Gemcitabine in Treating Patients With Recurrent Bladder Cancer That Has Not Responded to Previous Bacillus Calmette-Guerin
    Sletten Cancer Institute at Benefis Healthcare

    Trial Locations
    Sletten Cancer Institute at Benefis Healthcare
    Bladder Cancer
    Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
    Benefis Healthcare- Sletten Cancer Institute

    Trial Locations
    Benefis Healthcare- Sletten Cancer Institute
    Berdeaux, Donald MD (UIA Investigator)
    Stage I Bladder Cancer, Stage II Bladder Cancer, Stage III Bladder Cancer, Transitional Cell Carcinoma of the Bladder
    Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
    Berdeaux, Donald MD (UIA Investigator)
    Great Falls, Montana 59405
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Great Falls Clinic
    Great Falls, Montana 59405
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer